Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v16-FR | Version v15-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated | 2020-02-27 | 2020-02-27 |
| Drug Identification Number | 02248441 | 02248441 |
| Brand name | AVANDAMET | AVANDAMET |
| Common or Proper name | Rosiglitazone maleate and metformin hydrochloride tablet | Rosiglitazone maleate and metformin hydrochloride tablet |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | METFORMIN HYDROCHLORIDE ROSIGLITAZONE | METFORMIN HYDROCHLORIDE ROSIGLITAZONE |
| Strength(s) | 1000MG 4.00MG | 1000MG 4.00MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 100's | 100's |
| Additional packaging sizes | ||
| ATC code | A10BD | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2016-03-28 | 2016-03-28 |
| Estimated end date | ||
| Actual end date | 2017-04-20 | 2017-04-20 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | This product has been discontinued | This product has been discontinued |
| Health Canada comments |